| Symbol | SBFM |
|---|---|
| Name | SUNSHINE BIOPHARMA INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 333 LAS OLAS WAY,CU4 SUITE 433, FORT LAUDERDALE, 33301, Canada |
| Telephone | +1 954 - 330-0684 |
| Fax | — |
| — | |
| Website | https://www.sunshinebiopharma.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001402328 |
| Description | Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). Additional info from NASDAQ: |
New Form DEF 14C - Sunshine Biopharma Inc. <b>Filed:</b> 2026-06-08 <b>AccNo:</b> 0001683168-26-004616 <b>Size:</b> 64 KB
Read moreNew Form SCHEDULE 13G - Sunshine Biopharma Inc. <b>Filed:</b> 2026-05-22 <b>AccNo:</b> 0001079973-26-000719 <b>Size:</b> 8 KB
Read moreNew Form SCHEDULE 13G - Sunshine Biopharma Inc. <b>Filed:</b> 2026-05-21 <b>AccNo:</b> 0000921895-26-001471 <b>Size:</b> 31 KB
Read more(99% Neutral) SUNSHINE BIOPHARMA INC. (SBFM) Announces Business Combination
Read moreNew Form 424B4 - Sunshine Biopharma Inc. <b>Filed:</b> 2026-05-19 <b>AccNo:</b> 0001683168-26-004098 <b>Size:</b> 165 KB
Read moreDirector NATAN DAVID 🟢 acquired 100.0K shares of Sunshine Biopharma Inc. (SBFM) Transaction Date: Apr 14, 2026 | Filing ID: 002922
Read more(99% Positive) SUNSHINE BIOPHARMA INC. (SBFMW) Reports Q2 2026 Financial Results
Read moreNew Form 10-K - Sunshine Biopharma Inc. <b>Filed:</b> 2026-04-03 <b>AccNo:</b> 0001683168-26-002644 <b>Size:</b> 5 MB
Read moreNew Form NT 10-K - Sunshine Biopharma Inc. <b>Filed:</b> 2026-03-31 <b>AccNo:</b> 0001683168-26-002539 <b>Size:</b> 22 KB
Read more